Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIFI-OBESE: Probiotics in Paediatric Obesity
NCT03261466Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Nov 2013
- Primary completion
- Oct 2017
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Bifidobacterium breve BR03 and Bifidobacterium breve B632 in obesity, sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Started Nov 2013; status: completed.
02
Drugs
Bifidobacterium breve BR03Bifidobacterium breve B632
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03261466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261466.